CO2 FIBEROPTIC DELIVERY SYSTEM/BRONCHOSCOPIC USE
K-Number: K862835 · 1987-02-05
Advertisement
Device Summary
Frequently Asked Questions
What is the CO2 FIBEROPTIC DELIVERY SYSTEM/BRONCHOSCOPIC USE?
CO2 FIBEROPTIC DELIVERY SYSTEM/BRONCHOSCOPIC USE is a medical device that received FDA 510(k) clearance on 1987-02-05. The listed applicant is Cooper Lasersonics, Inc.. The 510(k) number is K862835.
When did CO2 FIBEROPTIC DELIVERY SYSTEM/BRONCHOSCOPIC USE receive FDA 510(k) clearance?
CO2 FIBEROPTIC DELIVERY SYSTEM/BRONCHOSCOPIC USE received FDA 510(k) clearance on 1987-02-05, under 510(k) number K862835.
Who is the listed applicant for CO2 FIBEROPTIC DELIVERY SYSTEM/BRONCHOSCOPIC USE?
The FDA 510(k) record lists Cooper Lasersonics, Inc. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for CO2 FIBEROPTIC DELIVERY SYSTEM/BRONCHOSCOPIC USE?
The FDA product code for CO2 FIBEROPTIC DELIVERY SYSTEM/BRONCHOSCOPIC USE is EOQ.
Related Clinical Trials
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Other records listing Cooper Lasersonics, Inc. as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: EOQ)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.
Advertisement